Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Telix Pharmaceuticals Limited - American Depositary Shares
(NQ:
TLX
)
7.080
-0.020 (-0.28%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Telix Pharmaceuticals Limited - American Depositary Shares
< Previous
1
2
3
4
5
6
Next >
Telix Full Year Results 2025 Investor Webcast Notification
February 03, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
January 20, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
January 16, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights
January 09, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
January 09, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
January 08, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
January 08, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
January 08, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
January 08, 2026
From
Schall Law
Via
GlobeNewswire
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
January 08, 2026
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026
January 07, 2026
From
Berger Montague
Via
GlobeNewswire
TLX DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
January 06, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th
January 05, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
January 05, 2026
From
Schall Law
Via
GlobeNewswire
UPCOMING DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
January 02, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
January 01, 2026
From
Schall Law
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 29, 2025
From
Schall Law
Via
GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
December 26, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 26, 2025
From
Schall Law
Via
GlobeNewswire
TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
December 23, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 22, 2025
From
Schall Law
Via
GlobeNewswire
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
December 21, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Telix Pharmaceuticals
December 21, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
TLX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
December 19, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 18, 2025
From
Schall Law
Via
GlobeNewswire
Robbins LLP Reminds Telix Pharmaceuticals Ltd. Stockholders About the January 9, 2026 Lead Plaintiff Deadline – Contact Us Today for Information About the TLX Class Action
December 15, 2025
From
Robbins LLP
Via
Business Wire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 15, 2025
From
Schall Law
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 12, 2025
From
Schall Law
Via
GlobeNewswire
TELIX CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights
December 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
